Search

Philip D Magnus

Deceased

from Austin, TX

Also known as:
  • Philip Magnus
  • Philip Dr Magnus
  • Philip Douglas Magnus
  • Phillip Magnus
3105 Windsor Rd, Austin, TX 78703

Philip Magnus Phones & Addresses

  • 3105 Windsor Rd, Austin, TX 78703
  • 3111 Windsor Rd, Austin, TX 78703
  • 1006 W 22Nd St, Austin, TX 78705
  • 1807 San Gabriel St, Austin, TX 78701
  • 5811 Mesa Dr #613, Austin, TX 78731
  • Bloomington, IN
  • PO Box 5552, Austin, TX 78763

Us Patents

  • Conversion Of ,-Unsaturated Ketones And ,-Unsaturated Esters Into -Hydroxy Ketones And -Hydroxy Esters Using Mn(Iii) Catalyst, Phenylsilane And Dioxygen

    view source
  • US Patent:
    6667410, Dec 23, 2003
  • Filed:
    Sep 14, 2001
  • Appl. No.:
    09/952326
  • Inventors:
    Philip D. Magnus - Austin TX
    Andrew H. Payne - Ware,
  • Assignee:
    Board of Regents, The University of Texas System - Austin TX
  • International Classification:
    C07J 500
  • US Classification:
    552585, 568377, 568388, 549200
  • Abstract:
    The present invention provides a novel process for the conversion of ,-unsaturated ketones. This invention is an improvement over existing processes in that it operates at neutral reaction conditions that prevent the formation of side reactions and that it is a single step, which proceeds with complete selectivity and gives a yield that is approximately 30% higher than the currently used processes. An example of this process is the conversion of 16-dehydroprogesterone into 17 -hydroxyprogesterone.
  • Efficient Synthesis Of Morphine And Codeine

    view source
  • US Patent:
    8293927, Oct 23, 2012
  • Filed:
    May 12, 2010
  • Appl. No.:
    12/778466
  • Inventors:
    Philip D. Magnus - Austin TX,
    Benjamin P. Fauber - San Francisco CA,
    Neeraj Sane - Pune,
  • Assignee:
    Board of Regents the University of Texas System - Austin TX
  • International Classification:
    C07D 307/94
  • US Classification:
    549345
  • Abstract:
    The present invention relates to methods for the synthesis of morphine, intermediates, salts and derivatives thereof. In preferred embodiments, the invention relates to methods for improving the efficiency and overall yield of said morphine, morphine related derivatives and intermediates thereof. In further embodiments, the invention relates to methods for improving the efficiency and overall yield of galanthamine and intermediates thereof.
  • Cross-Conjugated 2,5-Cyclohexadienone And Related Synthesis Methods

    view source
  • US Patent:
    8362283, Jan 29, 2013
  • Filed:
    May 12, 2010
  • Appl. No.:
    12/778392
  • Inventors:
    Philip D. Magnus - Austin TX,
    Benjamin P. Fauber - San Francisco CA,
    Neeraj Sane - Pune,
  • Assignee:
    Board of Regents, The University of Texas System - Austin TX
  • International Classification:
    C07D 317/70
    C07D 307/94
  • US Classification:
    549345, 549432, 544 69
  • Abstract:
    The present invention relates to methods for the synthesis of galanthamine, morphine, intermediates, salts and derivatives thereof. In preferred embodiments, the invention relates to methods for improving the efficiency and overall yield of said morphine, morphine related derivatives and intermediates thereof. In further embodiments, the invention relates to methods for improving the efficiency and overall yield of galanthamine and intermediates thereof.
  • Efficient Synthesis Of Galanthamine

    view source
  • US Patent:
    8450365, May 28, 2013
  • Filed:
    May 12, 2010
  • Appl. No.:
    12/778515
  • Inventors:
    Philip D. Magnus - Austin TX,
    Ben Fauber - San Francisco TX,
    Neeraj Sane - St. Patrick's Town,
  • Assignee:
    Board of Regents, The University of Texas System - Austin TX
  • International Classification:
    C07D 307/77
    A61K 31/343
  • US Classification:
    514468, 549429, 549457, 514461
  • Abstract:
    The present invention relates to methods for the synthesis of galanthamine, morphine, intermediates, salts and derivatives thereof. In preferred embodiments, the invention relates to methods for improving the efficiency and overall yield of said morphine, morphine related derivatives and intermediates thereof. In further embodiments, the invention relates to methods for improving the efficiency and overall yield of galanthamine and intermediates thereof.
  • Short Synthetic Route To Taxol And Taxol Derivatives

    view source
  • US Patent:
    55084478, Apr 16, 1996
  • Filed:
    May 24, 1994
  • Appl. No.:
    8/248083
  • Inventors:
    Philip D. Magnus - Austin TX
  • Assignee:
    Board of Regents, The University of Texas System - Austin TX
  • International Classification:
    C07D31306
  • US Classification:
    509354
  • Abstract:
    A short route to the total synthesis of the core skeleton of the taxol ring system is described. The same sequence of transformations can be carried out to make the 7-hydroxy series, and connect the additional carbon atoms required for the A-ring. The number of steps to the taxane skeleton is 13, making it the shortest route from readily available inexpensive starting materials.
  • Synthesis Of Navelbine Analogs

    view source
  • US Patent:
    52200167, Jun 15, 1993
  • Filed:
    Jul 29, 1991
  • Appl. No.:
    7/736300
  • Inventors:
    Philip D. Magnus - Austin TX
    Lee S. Thurston - Worthington OH
  • Assignee:
    Board of Regents, The University of Texas System - Austin TX
  • International Classification:
    C07D46100
    C07D22700
    C07B 4900
  • US Classification:
    540478
  • Abstract:
    The invention is a de novo synthesis of the norcatharanthine moiety of navelbine. The synthesis includes condensing a Grignard reagent prepared from an amine-protected R(+)-piperidinyl methanol with an N-protected 2-methoxyoxalyl indole. The indole N-protecting group is removed to provide a 2-methoxyindole hydroxy ester which is coupled to vindoline. After removal of the amineprotecting group from the piperidinyl group, ring closure to the indole moiety provides dihydrodesethyl navelbine. Other derivatives and analogs of navelbine with potential clinical applications in cancer chemotherapy may be readily synthesized. The synthesis opens a route to a wide variety of navelbine modifications, including modifications at or near the tryptamine bridge.
  • Synthesis Of Tetrahydroquinoline Enediyne Core Analogs Of Dynemicin

    view source
  • US Patent:
    54420652, Aug 15, 1995
  • Filed:
    Sep 9, 1993
  • Appl. No.:
    8/118862
  • Inventors:
    Philip D. Magnus - Austin TX
    Theodore Iliadis - Athens,
    Shane A. Eisenbeis - Austin TX
    Robin A. Fairhurst - Austin TX
  • Assignee:
    Board of Regents, The University of Texas System - Austin TX
  • International Classification:
    C07F 702
    C07D22106
    C07D22122
  • US Classification:
    546 14
  • Abstract:
    A process is described for the preparation of the core azobicyclo[7. 3. 1]tridecaenediyne moiety of the antitumor antibiotic dynemicin. The synthesis allows efficient production of the enediyne as a stable, compound in good yield from the adamantyl N-protected azabicyclo[7. 3. 1]tridecadiyne. The adamantyl protecting group is employed in the starting material, N-adamantyl dihydroquinoline or N-adamantyl 6-methoxy quinoline. Also disclosed are process for the synthesis of 3-hydroxy-6-methoxyquinoline and several N-substituted derivatives of azobicyclo[7. 3. 1]tridecaenediyne. Solid tumor and leukemia assays were performed on the analogs of dynemicin. The results suggest a method that these compounds will useful in treating certain types of leukemias and solid tumors. The disclosed synthesis provides a route to new dynemicin intermediates and analogs which will allow development of second and third generation dynemicins.
  • Process For Preparing Dibenzo-1-Carboxamido-1,4-Azabicyclo?3.2.1!Octanes

    view source
  • US Patent:
    57393370, Apr 14, 1998
  • Filed:
    Mar 8, 1996
  • Appl. No.:
    8/613030
  • Inventors:
    Philip D. Magnus - Austin TX
  • Assignee:
    Neurogen Corporation - Branford CT
  • International Classification:
    C07D22122
  • US Classification:
    546 72
  • Abstract:
    Disclosed are a process and novel compounds useful for preparing compounds of formula I ##STR1## wherein R. sub. 1 and R. sub. 2 independently represent hydrogen, inorganic or optionally substituted organic substituents; and R. sub. 3 is hydrogen, or an optionally substituted organic group, the process comprising cyclizing a tetrahydroisoquinoline of the formula ##STR2## where Y is a leaving group, in the presence of a stong base. The invention also encompasses a process for preparing the tetrahydroisoquinoline; and a process for converting the tetrahydroisoquinoline to the final amide I.

Wikipedia

Philip MagnusAllcroft

view source

Sir Philip Montefiore Magnus-Allcroft, 2nd Baronet (8 February 1906-21 December 1988), was a British biographer. Magnus-Allcroft was born in London, the ...

Philip Magnus

view source

Philip Magnus may refer to: Sir Philip Magnus, 1st Baronet (1842-1933), British educationalist and Unionist politician for London University (UK Parliament ...

Resumes

Philip Magnus Photo 1

Philip Magnus

view source

Googleplus

Philip Magnus Photo 2

Philip Magnus

Philip Magnus Photo 3

Philip Magnus

Youtube

Fly tying lessons 4 Magnus

I denna filmen binder jag Philip en Magnus fluga

  • Category:
    Sports
  • Uploaded:
    06 Dec, 2009
  • Duration:
    7m 29s

Philip og Magnus spiller minecraft

hej med jer

  • Category:
    Comedy
  • Uploaded:
    29 Dec, 2011
  • Duration:
    7m 55s

philip og magnus dungen [rs] 1

runescape

  • Category:
    Comedy
  • Uploaded:
    16 Dec, 2011
  • Duration:
    7m 11s

Daniel conor magnus philip hasse mediefag!

  • Category:
    People & Blogs
  • Uploaded:
    26 Feb, 2010
  • Duration:
    3m 21s

Get Report for Philip D Magnus from Austin, TXDeceased
Control profile